A test of infection should not be a "standard" for guiding TB preventive therapy in at-risk populations

Int J Tuberc Lung Dis. 2022 Nov 1;26(11):1092-1093. doi: 10.5588/ijtld.22.0445.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antitubercular Agents* / therapeutic use
  • Humans
  • Isoniazid
  • Tuberculin Test
  • Tuberculosis* / drug therapy
  • Tuberculosis* / prevention & control

Substances

  • Antitubercular Agents
  • Isoniazid